Hepatitis C Treatments
Find Hepatitis C Treatments
Medications for Hepatitis C
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hepatitis C.
Found 6 Approved Drugs for Hepatitis C
Sofosbuvir
Brand Names
Epclusa, Harvoni, Ledipasvir, Sovaldi, Vosevi
Sofosbuvir
Brand Names
Epclusa, Harvoni, Ledipasvir, Sovaldi, Vosevi
Form: Pellet, Tablet
Method of administration: Oral
FDA approval date: December 06, 2013
Classification: Hepatitis C Virus NS5A Inhibitor
EPCLUSA is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection [see Dosage and Administration.
Pegasys
Generic Name
PEGinterferon Alfa-2A
Pegasys
Generic Name
PEGinterferon Alfa-2A
Form: Injection
Method of administration: Subcutaneous
FDA approval date: October 16, 2002
Classification: Interferon alpha
PEGASYS is an inducer of the innate immune response indicated for the treatment of Chronic Hepatitis C (CHC).
Lamivudine
Brand Names
Abacavir, Cimduo, Combivir, Delstrigo, Dovato, Efavirenz, Epivir, SYMFI, Triumeq
Lamivudine
Brand Names
Abacavir, Cimduo, Combivir, Delstrigo, Dovato, Efavirenz, Epivir, SYMFI, Triumeq
Form: Tablet, Kit, Solution
Method of administration: Oral
FDA approval date: October 04, 2010
Classification: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Abacavir and lamivudine tablet, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 ) Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
Zepatier
Generic Name
Elbasvir
Zepatier
Generic Name
Elbasvir
Form: Tablet
Method of administration: Oral
FDA approval date: January 28, 2016
Classification: Hepatitis C Virus NS3/4A Protease Inhibitor
ZEPATIER ® is indicated for the treatment of chronic hepatitis C virus (HCV) genotype 1 or 4 infection in adults. ZEPATIER is indicated for use with ribavirin in certain patient populations [see Dosage and Administration.
Mavyret
Generic Name
Glecaprevir
Mavyret
Generic Name
Glecaprevir
Form: Pellet, Tablet
Method of administration: Oral
FDA approval date: August 03, 2017
Classification: Hepatitis C Virus NS3/4A Protease Inhibitor
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both [see Dosage and Administration.
Showing 1-5 of 6
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances